India Glycols Limited Announces Q1 Unaudited Financial Results for Quarter Ended June 30, 2026
India Glycols Limited has released its unaudited financial results for the first quarter ending June 30, 2026. The results cover both standalone and consolidated figures, which were reviewed by auditors and approved by the Board of Directors during a meeting held on August 12, 2026.The company's performance metrics for the quarter include Total Income of 2,987.30 units (presumably crores), up from 2,504.43 in the comparable quarter of the previous year. Total expenses amounted to 2,884.66 units for the quarter.
Financial results are presented below, comparing figures across various periods:
| Particulars | Quarter ended 30.06.2026 (Unaudited) | Quarter ended 31.03.2026 (Audited) | Quarter ended 30.06.2025 (Unaudited) | Year ended 31.03.2026 (Audited) |
|---|---|---|---|---|
| Total Income | 2,987.30 | 2,400.60 | 2,504.43 | 9,869.71 |
| Total Expenses | 2,884.66 | 2,264.82 | 2,434.30 | 9,502.18 |
Segmental Revenue Performance
The results detailed in the unaudited segment wise reports show clear performance across the company's major operational segments for the quarter ended June 30, 2026.Key revenue figures across the various segments include:
| Segment | Revenue (Q1 FY 2026) |
|---|---|
| Potable Spirits | 2,218.67 |
| Bio-based Specialities and Performance Chemicals | 361.73 |
| Bio-Fuel | 323.22 |
| Ennature Biopharma | 83.30 |
The revenue generation for the entire group in Q1 FY 2026 was recorded at 2,986.92 units (Unaudited).
Profitability and Per-Share Earnings
For the quarter ended June 30, 2026, the company reported significant figures related to profitability before tax and after tax:- Profit Before Tax: The company recorded a profit of 102.64 units (Before Tax).
- Tax Expense: The associated tax expense for the quarter was 13.27 units.
- Net Profit After Tax: The net profit after tax attributable to the owners of the Company stood at 76.59 units.
The earnings per equity share (face value of Rs 5 each), both Basic and Diluted, were reported at 11.43 units for the period.
Group Financial Highlights
A comparison of key financial metrics across the company and its subsidiaries/joint ventures shows:| Company Name | Revenue from operations | EBITDA |
|---|---|---|
| India Glycols Limited | 354.64 | 40.22 |
| IGL Spirits Limited | 2,541.89 | 120.10 |
| Ennature Bio Pharma Limited | 90.39 | 9.98 |
The company's segment liabilities were reported as follows for the quarter:
| Segment | Liabilities |
|---|---|
| Unallocated | 2,361.55 |
| Bio-based Specialities and Performance Chemicals | 577.54 |
| Potable Spirits | 385.41 |
| Bio-Fuel | 100.20 |
The management confirmed that the financial results align with recognition and measurement principles laid down in Indian Accounting Standard 34 (Ind AS), Interim Financial Reporting.
INDIAGLYCO Stock Price Movement
On Wednesday, shares of India Glycols Limited slipped by 2.16% to settle at ₹1049.4, as trading moved away from the previous close of ₹1073.1. The equity saw a total volume of 103,709 shares during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.